Sort
261,768 grants matching “gene therapy”
Innovative therapeutic approaches to treat chronic kidney disease
$875,000Andrew S. Terker · Vanderbilt University Medical Center · DP5 · FY2025 · OD
Biomedical Computing and Informatics Strategies for Infectious Disease Research
$874,977Jason H. Moore · University Of Pennsylvania · R01 · FY2018 · AI
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
$874,967Mark Scott Sundrud · Scripps Florida · R01 · FY2021 · AI
In vivo hematopoietic stem cell genetic modification by viral particles
$874,907Daniel Evan Bauer · Boston Children'S Hospital · R01 · FY2025 · HL
Investigating p16 Loss in Pro-tumorigenic Metabolism
$874,892Katherine Marie Aird · Wistar Institute · R37 · FY2025 · CA
Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias
$874,857Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2025 · AG
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
$874,817William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Targeting Residual ASCVD Risk by Integrating Genetics and Clinical Data
$874,792Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2024 · HL
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy
$874,780Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2019 · CA
Discovering Novel Drug Targets for CNS Edema by In Vitro Genetics
$874,725Ted Choi · Predictive Biology · R44 · FY2018 · NS
WASHINGTON UNIVERSITY HUMAN TUMOR ATLAS RESEARCH CENTER
$874,677Li Ding · Washington University · U2C · FY2023 · CA
Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias
$874,542Wei-Qi Wei · Vanderbilt University Medical Center · R56 · FY2024 · AG
Targeting the Endothelium in Sepsis
$874,540Robert C Flaumenhaft · Beth Israel Deaconess Medical Center · R01 · FY2014 · HL
BROAD-SPECTRUM RNAi THERAPEUTICS FOR FLAVIVIRAL ENCEPHALITIS
$874,476Manjunath Narasimha Swamy · Texas Tech University Health Scis Center · U01 · FY2009 · AI
TGF-betas in breast cancer progression
$874,425Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Development of TGF-beta antagonists for cancer therapy
$874,425Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Fluorescent IRE sensor for synucleinopathy drug discovery
$874,414Wen Shen · Lucerna, Inc. · R44 · FY2023 · NS
Mutational and Functional Analysis of Sporadic Malignant Melanoma
$874,394Yardena Samuels · National Human Genome Research Institute · ZIA · FY2011 · HG
Parasite-Derived Vesicles in Babesia virulence and Vaccine Development
$874,372Choukri Ben Mamoun · Yale University · R56 · FY2024 · AI
Metabolic Studies of Mouse Models of Obesity and Diabetes
$874,327Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2010 · DK
ENGINEERED HERPES SIMPLEX VIRUS FOR TREATMENT OF GLIOMAS
$874,304University Of Alabama At Birmingham · P01 · FY2000 · CA
Generation of Hematopoietic Stem and Progenitor Cells from Human iPSCs
$874,298Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Basic Research Support for the CCR
$874,282Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Human Variants
$874,239Joann B Sweasy · University Of Vermont & St Agric College · P01 · FY2014 · CA
Cellular Regulation in Genitourinary Development
$874,230William Donald Steers · University Of Virginia · P50 · FY2006 · DK